A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

ClinicalTrials.gov ID: NCT07038200

Public ClinicalTrials.gov record NCT07038200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

Study identification

NCT ID: NCT07038200
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Avidity Biosciences, Inc.; Industry
Enrollment: 200 participants

Conditions and interventions

Conditions

Interventions

AOC-1020 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 16 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 9, 2025
Primary completion: Apr 30, 2028
Completion: Jun 30, 2028
Last update posted: Jul 26, 2026

2025 – 2028

United States locations

U.S. sites: 14
U.S. states: 13
U.S. cities: 14

Facility	City	State	ZIP	Site status
University of California Irvine	Orange	California	92868	Active, not recruiting
Stanford University	Palo Alto	California	94304	Active, not recruiting
University of Colorado	Denver	Colorado	80045	Active, not recruiting
University of Florida	Gainesville	Florida	32608	Active, not recruiting
University of Iowa	Iowa City	Iowa	52242	Active, not recruiting
Kansas University Medical Center	Kansas City	Kansas	66205	Active, not recruiting
Kennedy Krieger Institute	Baltimore	Maryland	21205	Active, not recruiting
University of Massachusetts	Worcester	Massachusetts	01655	Active, not recruiting
University of Rochester Medical Center	Rochester	New York	14642	Active, not recruiting
Duke University	Durham	North Carolina	27708	Active, not recruiting
Ohio State University	Columbus	Ohio	43221	Active, not recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Active, not recruiting
University of Texas Health Science Center at San Antonio	San Antonio	Texas	78229	Active, not recruiting
Virginia Commonwealth University	Richmond	Virginia	23298	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07038200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 26, 2026 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07038200 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →